An interventional study of Shared Medical Decision Tool and Engaging Patients in Decision Making in Ovarian Cancer, sponsored by M.D. Anderson Cancer Center. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-07.
Sponsored by M.D. Anderson Cancer Center · Not applicable, Interventional, and Health services research
To develop a shared decision-making (SDM) tool to help Spanish-speaking patients make decisions about their maintenance therapy
Objectives:
2,695 studies on the registry are indexed under Ovarian Neoplasms; 726 are open to participants now.
This study's planned enrollment of 70 is above the median of 60 across 2,030 interventional studies indexed under Ovarian Neoplasms.
Browse Ovarian Neoplasms studies →M.D. Anderson Cancer Center is the lead sponsor of 2,999 studies on the registry; 579 are open to participants now.
Of its 599 completed or terminated interventional studies of FDA-regulated products, 402 (67%) have results posted.
Counted across the registry records on this site, refreshed daily.
Study population: This study will enroll patients and clinical providers.
Inclusion criteria: Patients
Exclusion criteria: Patients
Inclusion criteria: Clinicians
Exclusion criteria: Clinicians
Pre-testing and cognitive interviews for the Decision Support Tool
Other: Shared Medical Decision Tool · Behavioral: Engaging Patients in Decision Making · Behavioral: Literacy Spanish Language
Usual Care (Control Group) or Participants utilize the Decision Support Tool with Provider guidance (Intervention Group).
Other: Shared Medical Decision Tool · Behavioral: Engaging Patients in Decision Making · Behavioral: Literacy Spanish Language
standard of care
standard of care
standard of care
Decision Regret Scale questionnaire
This scale measures decisional regret related to health care decisions at a specific point in time. This tool consists of 5 questions answered on a Likert scale (1="Strongly agree" to 5="Strongly disagree").
Time frame: through study completion; an average of 2 year.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
M.D. Anderson Cancer Center